TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Aptose Reports Third Quarter 2025 Results

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Aptose Biosciences Inc.
Aptose Reports Third Quarter 2025 Results

Aptose Biosciences reported promising results for tuspetinib in treating newly diagnosed acute myeloid leukemia (AML), with 100% complete response rates at higher dose levels and plans to present updated data at the ASH Annual Meeting in December 2025.

Insights
HAFC   neutral

Mentioned only as providing advances to fund operations, with no significant positive or negative context